Clinical Trials
Kiniksa is committed to developing and commercializing novel therapies for diseases with unmet need, with a focus on cardiovascular indications. Clinical trials are research studies conducted with volunteers (also known as participants) to test investigational drugs for efficacy, safety, dosing, and potential side effects. This process helps researchers learn more about a disease and its diagnosis so they can determine potential ways to treat or prevent a disease. Regulatory authorities use clinical trial data and other information to decide if a new drug should be approved for commercial use.
For more information, please visit clinicaltrials.gov.
A PHASE 2/3 EFFICACY AND SAFETY STUDY OF KPL-387 TREATMENT IN PARTICIPANTS WITH RECURRENT PERICARDITIS
Brief Summary: This study is being conducted to demonstrate whether KPL-387 is an effective and safe treatment for recurrent pericarditis.
Condition or Disease: Pericarditis, Pericarditis Acute, Recurrent Pericarditis
Phase: Phase 2/Phase 3
Primary Outcome Measure:
Phase 2: Time to Treatment Response
Phase 3: Time to Pericarditis Recurrence
Long-Term Extension: Annualized rate of Pericarditis Recurrence